{"mainPropery":{"diseaseId":13070,"diseaseName":"Lewis-Sumner syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/13070/lewis-sumner-syndrome","synonyms":["MADSAM","Multifocal acquired demyelinating sensory and motor neuropathy"],"synonyms-with-source":[{"name":"MADSAM","source":"OrphaData.Org"},{"name":"Multifocal acquired demyelinating sensory and motor neuropathy","source":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=48162"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"48162"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":720,"resourceName":"GBS/CIDP Foundation International","abbreviation":"","address1":"375 East Elm Street, Suite 101","address2":"","address3":"","address4":"","address5":"","city":"Conshohocken","state":"PA","zip":"19428","country":"United States","phone":"+1-610-667-0131","tty":"","tollFree":"1-866-224-3301 (from North America)","fax":"+1-610-667-7036","email":"info@gbs-cidp.org","url":"https://www.gbs-cidp.org/","freeText":""}],"resource descriptions":[{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=48162' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":10935,"questionText":"What is Lewis-Sumner syndrome?<span class=\"Apple-tab-span\" style=\"white-space: pre;\">\t</span>","answerText":"<strong>Lewis-Sumner syndrome</strong> (also known as multifocal acquired demyelinating sensory and motor neuropathy) is a <a href=\"https://medlineplus.gov/neurologicdiseases.html\" target=\"_blank\">neurological condition</a> affecting primarily the arms and hands (upper limbs). The symptoms are a result of inflammation of the nerves leading to the upper body and the destruction of the fatty covering that protects the nerves (<a href=\"https://medlineplus.gov/ency/article/002261.htm\" target=\"_blank\">myelin sheath</a>). Lewis Sumner syndrome is an acquired disorder, and the exact cause of the condition is not known. Lewis Sumner syndrome may be difficult to distinguish from other forms of <a href=\"https://medlineplus.gov/ency/article/000777.htm\" target=\"_blank\">demyelinating neuropathies</a>, but diagnosis may be possible through <a href=\"https://medlineplus.gov/ency/article/003927.htm\" target=\"_blank\">nerve conduction studies</a> or a specific type of imaging test, called <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003335.htm\" target=\"_blank\">MRI</a>  with <a href=\"http://radiopaedia.org/articles/short-tau-inversion-recovery\" target=\"_blank\">T2 STIR</a>.[11984] Treatment with <a href=\"http://emedicine.medscape.com/article/210367-overview\" target=\"_blank\">intravenous immunoglobulin (IVIg) therapy</a> has been successful in reducing the symptoms of the disease.[11985][11986][11987]<br />","dateModified":"2016-08-04T20:07:00"},"basicQuestions":[{"questionId":10936,"questionText":"What are the symptoms of Lewis-Sumner syndrome?<span class=\"Apple-tab-span\" style=\"white-space: pre;\">\t</span>","answerText":"The signs and symptoms of Lewis-Sumner syndrome present during adulthood and include hand and arm weakness, a loss of reflexes in the upper limbs (areflexia), loss of feeling in the hands and fingers (neuropathy), and tingling in the hands and fingers (<a href=\"http://www.ninds.nih.gov/disorders/paresthesia/paresthesia.htm\" target=\"_blank\">paresthesias</a>). Some people affected by Lewis-Sumner syndrome also experience pain in the upper limbs. L-SS may also affect the legs and feet (lower limbs).[11984]","dateModified":"2016-08-04T20:20:00","resourceClassificationName":"Symptoms","references":[{"referenceId":11984,"authors":"Rajabally YA, Knopp MJ, Martin-Lamb D, Morlese J","articleTitle":"Diagnostic value of MR imaging in the Lewis-Sumner syndrome: a case series","bookWebsiteJournalTitle":"","date":"July 15, 2014","volume":"342(1-2)","pages":"182-185","url":"http://www.ncbi.nlm.nih.gov/pubmed/24825730","authors2":"","placeOfPublication":"Journal of the Neurological Sciences","publisher":""}]},{"questionId":10938,"questionText":"How is Lewis-Sumner syndrome diagnosed?","answerText":"The diagnosis of Lewis-Sumner syndrome consists of a clinical evaluation showing symptoms of Lewis-Sumner disease, as well as <a href=\"https://medlineplus.gov/ency/article/003927.htm\" target=\"_blank\">nerve conduction studies</a> showing the involvement of the nerves leading to the upper limbs. Nerve conduction studies use electrical stimulation to measure how well the nerves are working. The diagnosis can be confirmed by performing a specific type of imaging test called <a href=\"http://mri-q.com/stir.html\" target=\"_blank\">MRI T2 STIR</a>. This imaging technique allows for clearer viewing of the <a href=\"https://medlineplus.gov/ency/article/002239.htm\" target=\"_blank\">brachial plexus</a>, which is one of the nerve networks that is often affected by Lewis-Sumner syndrome.[11984]","dateModified":"2016-08-04T21:28:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":11984,"authors":"Rajabally YA, Knopp MJ, Martin-Lamb D, Morlese J","articleTitle":"Diagnostic value of MR imaging in the Lewis-Sumner syndrome: a case series","bookWebsiteJournalTitle":"","date":"July 15, 2014","volume":"342(1-2)","pages":"182-185","url":"http://www.ncbi.nlm.nih.gov/pubmed/24825730","authors2":"","placeOfPublication":"Journal of the Neurological Sciences","publisher":""}]},{"questionId":10937,"questionText":"What is the cause of Lewis-Sumner syndrome?","answerText":"Lewis-Sumner syndrome is an acquired condition, meaning that the symptoms of the disease are not present at birth. The disease is not believed to be genetic, meaning that it is not known to be caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) to our <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>.[11987] In some cases, Lewis-Sumner syndrome is a side-effect of a type of medication called antagonists of TNF-alpha (<a href=\"http://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Anti-TNF\" target=\"_blank\">anti-TNF&alpha;</a>) This type of medication may be used for treatment of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001243.htm\" target=\"_blank\">arthritis</a>  and <a href=\"http://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/basics/definition/con-20034908\" target=\"_blank\">inflammatory bowel disease</a>.[11985]","dateModified":"2016-08-04T21:23:00","resourceClassificationName":"Cause","references":[{"referenceId":11985,"authors":"Cirillo G, Todisco V, Tedeschi G","articleTitle":"Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis","bookWebsiteJournalTitle":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","date":"June 2016","volume":"37(6)","pages":"1005-1008","url":"http://www.ncbi.nlm.nih.gov/pubmed/26838522","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11987,"authors":"Jean-Michel Vallat","articleTitle":"Chronic inflammatory demyelinating polyneuropathy","bookWebsiteJournalTitle":"","date":"December 2010","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=2932","authors2":"","placeOfPublication":"","publisher":"Orphanet"}]},{"questionId":10939,"questionText":"What is the treatment for Lewis-Sumner syndrome?","answerText":"The treatment most commonly used for Lewis-Sumner syndrome is <a href=\"https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/immunoglobulin-(IgG)-replacement-therapy\" target=\"_blank\">intravenous immunoglobulins (IVIg)</a>. This type of therapy uses a mixture of antibodies delivered through an IV to help alleviate the symptoms of the disease, and is successful in 80% of cases. For individuals who do not respond to IVIg, treatment with subcutaneous immunoglobulins or <a href=\"http://www.mgawpa.org/pdfs/Medical/Information%20on%20Plasma%20Exchange.pdf\" target=\"_blank\">plasma exchange</a> have proved effective.[11988][11989] Up to 40% of individuals who are not responsive to treatment eventually experience a reduction in symptoms.[11990]&nbsp;","dateModified":"2016-08-04T21:32:00","resourceClassificationName":"Treatment","references":[{"referenceId":11988,"authors":"Young-Eun Park, Ji-Won Yook, and Dae-Seong Kim","articleTitle":"A Case of Lewis-Sumner Syndrome Showing Dramatic Improvement after Plasma Exchange","bookWebsiteJournalTitle":"Journal of Korean Medical Science","date":"June 16, 2010","volume":"25(7)","pages":"1101-1104","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890894/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11989,"authors":"Bayas A, Gold R, Naumann M","articleTitle":"Long-term treatment of Lewis-Sumner syndrome with subcutaneous immunoglobulin infusions","bookWebsiteJournalTitle":"Journal of the Neurological Sciences","date":"January 15, 2013","volume":"324(1-2)","pages":"53-56","url":"http://www.ncbi.nlm.nih.gov/pubmed/23095259","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11990,"authors":"Rajabally YA, Chavada G","articleTitle":"Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features","bookWebsiteJournalTitle":"Muscle & Nerve","date":"February 2009","volume":"39(2)","pages":"206-220","url":"http://www.ncbi.nlm.nih.gov/pubmed/19145651","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6102,"relatedDiseaseName":"Chronic inflammatory demyelinating polyneuropathy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Lewis-Sumner_syndrome"}